Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies.
Luca ProsperiniCarla TortorellaShalom HaggiagSerena RuggieriSimonetta GalganiClaudio GasperiniPublished in: Journal of neurology (2021)
Our pooled analysis suggests a 24%-increased risk of death from COVID-19 in patients with MS. These findings must be interpreted with caution, mainly because of the difficulties in COVID-19 case detection (especially in the first pandemic wave) and heterogeneity of the analyzed cohorts. Confirmation in larger population-based studies is warranted.